Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 16596222)

2.

Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).

Morikawa J, Li H, Kim S, Nishi K, Ueno S, Suh E, Dougherty E, Shmulevich I, Shiku H, Zhang W, Kobayashi T.

Int J Oncol. 2003 Sep;23(3):617-25.

PMID:
12888896
3.

Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.

Bullinger L, Rücker FG, Kurz S, Du J, Scholl C, Sander S, Corbacioglu A, Lottaz C, Krauter J, Fröhling S, Ganser A, Schlenk RF, Döhner K, Pollack JR, Döhner H.

Blood. 2007 Aug 15;110(4):1291-300. Epub 2007 May 7.

4.

Prognostically useful gene-expression profiles in acute myeloid leukemia.

Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R.

N Engl J Med. 2004 Apr 15;350(16):1617-28.

5.

Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.

Lindvall C, Furge K, Björkholm M, Guo X, Haab B, Blennow E, Nordenskjöld M, Teh BT.

Haematologica. 2004 Sep;89(9):1072-81.

6.

Identification of gene expression profiles that segregate patients with childhood leukemia.

Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith FE, Willman C, Wei Q, Hunger SP, Carroll WL.

Clin Cancer Res. 2002 Oct;8(10):3118-30.

7.

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R, Döhner H, Pollack JR.

N Engl J Med. 2004 Apr 15;350(16):1605-16.

8.

Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.

Heuser M, Wingen LU, Steinemann D, Cario G, von Neuhoff N, Tauscher M, Bullinger L, Krauter J, Heil G, Döhner H, Schlegelberger B, Ganser A.

Haematologica. 2005 Nov;90(11):1484-92.

9.

Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.

Radmacher MD, Marcucci G, Ruppert AS, Mrózek K, Whitman SP, Vardiman JW, Paschka P, Vukosavljevic T, Baldus CD, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD; Cancer and Leukemia Group B.

Blood. 2006 Sep 1;108(5):1677-83. Epub 2006 May 2.

10.

Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.

Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, Lister TA, Young BD.

Genes Chromosomes Cancer. 2003 Jun;37(2):149-58.

PMID:
12696063
11.

Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?

Willman CL.

Best Pract Res Clin Haematol. 2008 Mar;21(1):21-8. doi: 10.1016/j.beha.2007.11.008.

PMID:
18342809
12.

CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.

Oyan AM, Bø TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland KH, Bruserud O.

Cytometry B Clin Cytom. 2005 Mar;64(1):18-27.

13.

Gene expression profile related to prognosis of acute myeloid leukemia.

Park MH, Cho SA, Yoo KH, Yang MH, Ahn JY, Lee HS, Lee KE, Mun YC, Cho DH, Seong CM, Park JH.

Oncol Rep. 2007 Dec;18(6):1395-402.

PMID:
17982622
14.

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.

Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ, Lister TA, Fitzgibbon J.

Genes Chromosomes Cancer. 2003 May;37(1):72-8.

PMID:
12661007
15.

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT.

BMC Cancer. 2009 Mar 5;9:77. doi: 10.1186/1471-2407-9-77.

16.

DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines.

Court EL, Smith MA, Avent ND, Hancock JT, Morgan LM, Gray AG, Smith JG.

Leuk Res. 2004 Jul;28(7):743-53.

PMID:
15158096
17.

A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.

Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S.

Cytometry B Clin Cytom. 2008 Jan;74(1):25-9.

18.

Platelet production and related pathophysiology in acute myelogenous leukemia at first diagnosis: prognostic implications.

Trafalis DT, Poulakidas E, Kapsimali V, Tsigris C, Papanicolaou X, Harhalakis N, Nikiforakis E, Mentzikof-Mitsouli C.

Oncol Rep. 2008 Apr;19(4):1021-6.

PMID:
18357391
19.

Identification of gene expression signatures for molecular classification in human leukemia cells.

Song JH, Kim HJ, Lee CH, Kim SJ, Hwang SY, Kim TS.

Int J Oncol. 2006 Jul;29(1):57-64.

PMID:
16773185
20.

Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.

Silva FP, Swagemakers SM, Erpelinck-Verschueren C, Wouters BJ, Delwel R, Vrieling H, van der Spek P, Valk PJ, Giphart-Gassler M.

Blood. 2009 Oct 1;114(14):3001-7. doi: 10.1182/blood-2009-03-211334. Epub 2009 Aug 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk